Skip to content

Medicated kashaya for pittaja mutrakrichra(urinary tract infection).

A Randomised controlled clinical study of Kallurvanjyadi Kashaya in the management of Pittaja Mutrakrichra. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086156
Enrollment
40
Registered
2025-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Dr.Akash R Terdal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will fulfill the diagnostic criteria. Patients with age group between 18 to 60 years (Both age inclusive). Patients who are willing to enroll in the research and sign the consent form.

Exclusion criteria

Exclusion criteria: Pittaja mutrakrichra due to bastimarmabhighata. Patients having STD Patient with Congenital Deformity Secondary to a disorder like Renal Calculi, BPH, Acute Renal Failure, Diabetes mellitus, vesico-ureteric reflux, malignancy related to genitourinary tract, Renal Tuberculosis. Pregnant and Lactating women will be excluded.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Kallurvanjyadi Kashaya in the management of Pittaja Mutrakrichra. Timepoint: 15 days

Secondary

MeasureTime frame
objective parameter assessed Pus Cells / hpf Epithelial Cells /hpf RBC s / hpf Timepoint: on 14th day

Countries

India

Contacts

Public ContactDr Akash R Terdal

Alvas Ayurveda Medical College

shettysusheel13@gmail.com9980431676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026